OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.
Identifieur interne : 000D39 ( Main/Exploration ); précédent : 000D38; suivant : 000D40OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.
Auteurs : J. Zhang [Royaume-Uni] ; E. Moore [Royaume-Uni] ; R. Bousfield [Royaume-Uni]Source :
- European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [ 1435-4373 ] ; 2016.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Antibactériens (administration et posologie), Cellulite sous-cutanée (microbiologie), Cellulite sous-cutanée (traitement médicamenteux), Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Perfusions parentérales, Résultat thérapeutique, Soins ambulatoires, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
- MESH :
- administration et posologie : Antibactériens.
- microbiologie : Cellulite sous-cutanée.
- traitement médicamenteux : Cellulite sous-cutanée.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Perfusions parentérales, Résultat thérapeutique, Soins ambulatoires, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Anti-Bacterial Agents.
- drug therapy : Cellulitis.
- microbiology : Cellulitis.
- Adolescent, Adult, Aged, Aged, 80 and over, Ambulatory Care, Female, Humans, Infusions, Parenteral, Male, Middle Aged, Retrospective Studies, Risk Factors, Treatment Outcome, Young Adult.
Abstract
This retrospective study investigated the demographics and treatment outcomes of patients with cellulitis receiving outpatient parenteral antibiotic therapy (OPAT) between 2010 and 2014 in Cambridge University Hospitals. The rate of treatment failure (as indicated by the readmission to hospital) was low, at 5.5%. Risk factors associated with a longer duration of OPAT treatment included: immunosuppression, peripheral vascular disease, obesity, lymphoedema, previous cellulitis and diabetes.
DOI: 10.1007/s10096-016-2631-y
PubMed: 27084095
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000873
- to stream PubMed, to step Curation: 000873
- to stream PubMed, to step Checkpoint: 000873
- to stream Ncbi, to step Merge: 008183
- to stream Ncbi, to step Curation: 008183
- to stream Ncbi, to step Checkpoint: 008183
- to stream Main, to step Merge: 000D40
- to stream Main, to step Curation: 000D39
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.</title><author><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name><affiliation wicri:level="4"><nlm:affiliation>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK. jz325@cam.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Moore, E" sort="Moore, E" uniqKey="Moore E" first="E" last="Moore">E. Moore</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea><wicri:noRegion>CB2 0QQ</wicri:noRegion></affiliation></author><author><name sortKey="Bousfield, R" sort="Bousfield, R" uniqKey="Bousfield R" first="R" last="Bousfield">R. Bousfield</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea><wicri:noRegion>CB2 0QQ</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27084095</idno><idno type="pmid">27084095</idno><idno type="doi">10.1007/s10096-016-2631-y</idno><idno type="wicri:Area/PubMed/Corpus">000873</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000873</idno><idno type="wicri:Area/PubMed/Curation">000873</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000873</idno><idno type="wicri:Area/PubMed/Checkpoint">000873</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000873</idno><idno type="wicri:Area/Ncbi/Merge">008183</idno><idno type="wicri:Area/Ncbi/Curation">008183</idno><idno type="wicri:Area/Ncbi/Checkpoint">008183</idno><idno type="wicri:Area/Main/Merge">000D40</idno><idno type="wicri:Area/Main/Curation">000D39</idno><idno type="wicri:Area/Main/Exploration">000D39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.</title><author><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name><affiliation wicri:level="4"><nlm:affiliation>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK. jz325@cam.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Moore, E" sort="Moore, E" uniqKey="Moore E" first="E" last="Moore">E. Moore</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea><wicri:noRegion>CB2 0QQ</wicri:noRegion></affiliation></author><author><name sortKey="Bousfield, R" sort="Bousfield, R" uniqKey="Bousfield R" first="R" last="Bousfield">R. Bousfield</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea><wicri:noRegion>CB2 0QQ</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title><idno type="eISSN">1435-4373</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Ambulatory Care</term><term>Anti-Bacterial Agents (administration & dosage)</term><term>Cellulitis (drug therapy)</term><term>Cellulitis (microbiology)</term><term>Female</term><term>Humans</term><term>Infusions, Parenteral</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antibactériens (administration et posologie)</term><term>Cellulite sous-cutanée (microbiologie)</term><term>Cellulite sous-cutanée (traitement médicamenteux)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Perfusions parentérales</term><term>Résultat thérapeutique</term><term>Soins ambulatoires</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cellulitis</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Cellulite sous-cutanée</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Cellulitis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Cellulite sous-cutanée</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Ambulatory Care</term><term>Female</term><term>Humans</term><term>Infusions, Parenteral</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Perfusions parentérales</term><term>Résultat thérapeutique</term><term>Soins ambulatoires</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This retrospective study investigated the demographics and treatment outcomes of patients with cellulitis receiving outpatient parenteral antibiotic therapy (OPAT) between 2010 and 2014 in Cambridge University Hospitals. The rate of treatment failure (as indicated by the readmission to hospital) was low, at 5.5%. Risk factors associated with a longer duration of OPAT treatment included: immunosuppression, peripheral vascular disease, obesity, lymphoedema, previous cellulitis and diabetes.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Angleterre de l'Est</li></region><settlement><li>Cambridge</li></settlement><orgName><li>Université de Cambridge</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name></region><name sortKey="Bousfield, R" sort="Bousfield, R" uniqKey="Bousfield R" first="R" last="Bousfield">R. Bousfield</name><name sortKey="Moore, E" sort="Moore, E" uniqKey="Moore E" first="E" last="Moore">E. Moore</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27084095
|texte= OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27084095" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |